Ultralife (ULBI) Receivables (2010 - 2026)

Ultralife's Receivables history runs 17 years deep, the most recent figure standing at $34.4 million for Q1 2026.

• On a quarterly basis, Receivables fell 4.53% year-over-year to $34.4 million in Q1 2026; TTM through Mar 2026 was $34.4 million, a 4.53% decrease from a year earlier, with the FY2025 full-year figure at $33.9 million, up 15.59% from the prior year.
• Receivables advanced to $34.4 million in Q1 2026 per ULBI's latest filing, from $33.9 million in the prior quarter.
• Across five years, Receivables topped out at $36.1 million in Q1 2025 and bottomed at $22.3 million in Q2 2022.
• The 5-year median for Receivables is $29.4 million (2024), against an average of $29.6 million.
• Across the five-year window, Receivables surged 65.54% in 2022 and dropped 7.53% in 2024, its largest moves.
• Year by year, Receivables stood at $27.8 million in 2022, then increased by 14.33% to $31.8 million in 2023, then slipped by 7.53% to $29.4 million in 2024, then advanced by 15.59% to $33.9 million in 2025, then gained by 1.41% to $34.4 million in 2026.
• Per Business Quant, the three latest ULBI Receivables figures stand at $34.4 million (Q1 2026), $33.9 million (Q4 2025), and $30.9 million (Q3 2025).